Classical Complement Pathway Inhibition in a “Human‐On‐A‐Chip” Model of Autoimmune Demyelinating Neuropathies-论文-万方医学网

Classical Complement Pathway Inhibition in a “Human‐On‐A‐Chip” Model of Autoimmune Demyelinating Neuropathies

导出原文传递

翻译打印收藏纠错

作者： John W. Rumsey ^[1] ; Case Lorance ^[2] ; Max Jackson ^[3] ; Trevor Sasserath ^[4] ; Christopher W. McAleer ^[5] ; Christopher J. Long ^[6] ; Arindom Goswami ^[7] ; Melissa A. Russo ^[8] ; Shruti M. Raja ; Karissa L. Gable ; Doug Emmett ; Lisa D. Hobson‐Webb ; Manisha Chopra ; James F. Howard ; Jeffrey T. Guptill ; Michael J. Storek ; Miguel Alonso‐Alonso ; Nazem Atassi ; Sandip Panicker ; Graham Parry ; Timothy Hammond ; James J. Hickman

作者单位： Hesperos, Inc ^[1] NanoScience Technology Center,University of Central Florida ^[2] Immunology and Inflammation,Sanofi ^[3] Neurology Early Development,Sanofi ^[4] Bioverativ ^[5] Neurological Diseases,Sanofi ^[6] Division of Neuromuscular Disease, Department of Neurology,Duke University Medical Center ^[7] Department of Neurology, The University of North Carolina – Chapel Hill,School of Medicine ^[8]

关键词 autoimmune demyelinating neuropathies complement inhibition drug efficacy human‐on‐a‐chip rare diseases

发布时间 2024-04-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除